Human osteocalcin: a strong promoter for nitric oxide synthase gene therapy, with specificity for hormone refractory prostate cancer. [electronic resource]
- The journal of gene medicine Jun 2007
- 511-20 p. digital
Publication Type: Journal Article
1099-498X
10.1002/jgm.1045 doi
Cell Death Cell Line, Tumor Cytomegalovirus Genetic Therapy Green Fluorescent Proteins--metabolism Humans Male Neoplasms, Hormone-Dependent--enzymology Nitric Oxide Synthase Type II--genetics Nitrites--metabolism Osteocalcin--genetics Promoter Regions, Genetic--genetics Prostatic Neoplasms--enzymology Transfection